Hycamtin 1mg Tablet
Prescription Required
Product introduction
Hycamtin 1mg Tablet is used in the treatment of ovarian cancer. It shows its working by stopping or slowing down the growth of cancer cells.
Hycamtin 1mg Tablet is used to treat various types of cancer
Hycamtin 1mg Tablet is used to treat various types of cancer
Uses of Hycamtin Tablet
Benefits of Hycamtin Tablet
In Ovarian cancer
Ovarian cancer is a cancer that begins in the female organs that produce eggs (ovaries). This type of cancer is usually detected very late and can be fatal too. It usually spreads to the pelvis and stomach. Hycamtin 1mg Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective medicine but has some side effects that may be bothersome. Consult your doctor to know about ways that can help you avoid these side effects.
Side effects of Hycamtin Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Hycamtin
- Tiredness
- Vomiting
- Weakness
- Nausea
- Abdominal pain
- Indigestion
- Decreased white blood cell count
- Decreased blood cells (red cells, white cells, and platelets)
- Diarrhea
How to use Hycamtin Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Hycamtin 1mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
SAFE
Consuming alcohol with Hycamtin 1mg Tablet does not cause any harmful side effects.
Pregnancy
CONSULT YOUR DOCTOR
Hycamtin 1mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
UNSAFE
Hycamtin 1mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
UNSAFE
Hycamtin 1mg Tablet may cause side effects which could affect your ability to drive.
Hycamtin 1mg Tablet can make you feel tired and this may affect your ability to drive.
Hycamtin 1mg Tablet can make you feel tired and this may affect your ability to drive.
Kidney
CAUTION
Hycamtin 1mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Hycamtin 1mg Tablet may be needed. Please consult your doctor.
Use of Hycamtin 1mg Tablet is not recommended in patients with end-stage kidney disease.
Use of Hycamtin 1mg Tablet is not recommended in patients with end-stage kidney disease.
Liver
SAFE IF PRESCRIBED
Hycamtin 1mg Tablet is safe to use in patients with liver disease. No dose adjustment of Hycamtin 1mg Tablet is recommended.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Hycamtin 1mg Tablet helps treat ovarian cancer.
- Swallow it whole. Do not chew, crush or break the tablet.
- It may cause diarrhea. Drink plenty of fluids and inform your doctor If you experience more than three episodes of diarrhoea per day while having treatment with this medicine.
- Do not drive or operate machinery as Hycamtin 1mg Tablet may cause tiredness, drowsiness or weakness.
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine.
- Your doctor may get regular blood tests done to monitor your blood cells during treatment with this medicine.
- Inform your doctor immediately if you notice any signs of infection such as fever, sore throat, rash or severe diarrhea.
Fact Box
Chemical Class
Camptothecin Derivative
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Topoisomerase Inhibitor
Patient concerns
User feedback
Patients taking Hycamtin 1mg Tablet
Twice A Day
40%
Once A Day
40%
Once A Week
20%
What are you using Hycamtin Tablet for?
Ovarian cance*
62%
Cervical canc*
38%
*Ovarian cancer, Cervical cancer
How much was the improvement?
Poor
44%
Excellent
33%
Average
22%
What were the side-effects while using Hycamtin 1mg Tablet?
Reduced blood*
33%
Vomiting
17%
Fatigue
17%
Nausea
17%
Hair loss
17%
*Reduced blood platelets
How do you take Hycamtin Tablet?
Empty stomach
33%
With food
33%
With or witho*
33%
*With or without food
Please rate Hycamtin 1mg Tablet on price
Expensive
67%
Average
33%
FAQs
How often is Hycamtin 1mg Tablet given?
Generally Hycamtin 1mg Tablet treatment is for 4 cycles of 21 day each, patient is given Hycamtin 1mg Tablet for first 5 days of each cycle.
Does Hycamtin 1mg Tablet cause hair loss?
Yes, Hycamtin 1mg Tablet may cause temporary hair loss.
Does Hycamtin 1mg Tablet cause flare reaction?
Yes, Hycamtin 1mg Tablet may cause flare reaction.
How long does Hycamtin 1mg Tablet take to work?
Hycamtin 1mg Tablet may start its action once the infusion is started, however, the complete effect may be assessed only after completion of 4 cycles.
Is Hycamtin 1mg Tablet a vesicant?
Hycamtin 1mg Tablet is a vesicant (irritant).
Is Hycamtin 1mg Tablet effective?
Yes Hycamtin 1mg Tablet is effective if used at prescribed doses for the prescribed duration as advised by your doctor.
What is Hycamtin 1mg Tablet chemotherapy?
It is a treatment therapy that includes Hycamtin 1mg Tablet with or without combination of other drugs in treatment of cancer (Usually ovarian or lung cancer).
How is Hycamtin 1mg Tablet administered?
Hycamtin 1mg Tablet is either administered orally as a capsule or as an intravenous Infusion in the arm over a period of 30 min.
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1711-12.
- Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 951.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1383.
Marketer details
Name: Glaxo SmithKline Pharmaceuticals Ltd
Address: Dr. Annie Besant Road, Mumbai - 400 030
Country of origin: India
Lab tests offered by us
Related/Popular tests
DISCONTINUED
We do not facilitate sale of this product at present